Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Curr Med Chem ; 16(15): 1850-62, 2009.
Article in English | MEDLINE | ID: mdl-19442150

ABSTRACT

Epinephrine and Norepinephrine, typically released during stress bind to nine different adrenoceptors (AR) which classically control the cardiovascular and respiratory systems. New targets were described for the many agonists and antagonists developed for these AR, as the central nervous system. During the last three decades, AR expression and action on the mammary gland/breast were extensively investigated. In the cow mammary gland, good milkability was associated with low density of beta(2)-AR and high density of alpha(2)-AR. In the rat normal mammary gland, beta-AR are expressed in the epithelial cells, alveoli, ducts, and adipocytes showing an exquisite regulation by steroid hormones and prolactin. In rat dimethylbenz(a)anthracene (DMBA) tumors, a close correlation was observed between tumor growth and beta-AR concentration. beta(2)-AR were described in numerous human cell lines and breast tumors. The action of beta-adrenergic compounds on cell proliferation is contradictory. While some authors found that beta-agonists significantly inhibit cancer cell proliferation and tumor growth in mice, others described a significant reduction in DNA synthesis by beta-blockers. Also, positive effects of beta-AR on human carcinoma cell migration have been described. alpha(2)-AR are expressed in human breast cancer and non-cancer cell lines, their stimulation being associated with increased cell proliferation. In vivo clonidine increased tumor growth and alpha (2)-adrenergic antagonists completely reversed this effect. When administered alone, rauwolscine inhibited tumor growth behaving as an inverse agonist. Therefore, the numerous adrenergic beta- and alpha-AR agonists or antagonists could prove to be unexpected therapeutic options for mammary gland/ breast and mainly breast cancer.


Subject(s)
Breast Neoplasms/drug therapy , Receptors, Adrenergic/metabolism , Animals , Breast Neoplasms/metabolism , Female , Humans , Signal Transduction
2.
Eur J Immunol ; 31(12): 3413-21, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11745360

ABSTRACT

Wiskott-Aldrich syndrome (WAS) is an X-linked disorder characterized by congenital thrombocytopenia and progressive deterioration of the immune function. Dendritic cells (DC) are key effectors in the induction of specific immunity and are highly specialized in antigen uptake and subsequent migration to draining lymph nodes. DC were generated in vitro from circulating monocytes from ten WAS patients characterized by a different disease score. Immature DC showed similar morphology and membrane phenotype, as compared to normal DC. In chemotaxis assay, immature DC had a reduced migration in response to MIP-1alpha/CCL3, but efficiently endocytosed the macromolecules FITC-dextran and FITC-albumin. Upon terminal differentiation with LPS or CD40 ligand, the acquisition of a mature surface phenotype was variably achieved among WAS patients, with increased expression of CD80, CD86 and DC-LAMP. In contrast, the expression of CD83 was usually low. A defective up-regulation of CD83 was also observed in the lymph node from one WAS patient, whose DC stained positively for DC-LAMP. Mature DC from all the patients tested, but one, significantly migrated in vitro in response to MIP-3beta, a finding confirmed in vivo by the detection of HLA-DR/DC LAMP-positive cells in secondary lymphoid organs. When tested in MLR assays, both immature and mature WAS DC induced allogenic T cell proliferation in a manner comparable to control DC. Collectively these results suggest that, although many functional activities of WAS DC are essentially similar to normal DC, subtle and selective alterations of DC differentiation were also observed, with reduced migratory activity of immature DC and defective CD83 expression upon maturation.


Subject(s)
Dendritic Cells/physiology , Immunoglobulins/analysis , Membrane Glycoproteins/analysis , Monocytes/physiology , Wiskott-Aldrich Syndrome/immunology , Antigen-Presenting Cells/physiology , Antigens, CD/analysis , B7-2 Antigen , Cell Movement , Endocytosis , Humans , Lymphocyte Activation , T-Lymphocytes/immunology , CD83 Antigen
3.
Biochem Genet ; 37(3-4): 95-107, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10495885

ABSTRACT

Ethanol tolerance, alcohol dehydrogenase (ADH; EC 1.1.1.1) activity, and tissue-specific expression were examined in species of the cardini group of Drosophila using D. melanogaster as a standard of comparison. In contrast to most fruit-breeding species, all cardini species examined, two from the cardini subgroup and five from the dunni subgroup, were ethanol sensitive (LC50 < or = 2.05%) and the mean ADH activity of males ranges from only 8 to 16% that of D. melanogaster AdhFF. Among all seven cardini species, there were small but significant differences in ethanol tolerance and ADH activity. Differences in enzyme mobility were in accordance with the proposed phylogeny for the dunni-subgroup species. ADH is expressed in the fat body and midgut. Males of D. acutilabella and of D. belladunni have significantly less ethanol tolerance and express less ADH activity than females in zymograms and histological preparations.


Subject(s)
Adaptation, Physiological , Alcohol Dehydrogenase/metabolism , Drosophila/physiology , Ethanol/pharmacology , Alcohol Dehydrogenase/genetics , Alleles , Animals , Drosophila/enzymology , Electrophoresis, Polyacrylamide Gel , Female , Male , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...